Feast Ventures

The fund invests exclusively at the intersection of agriculture, food, nutrition, data and preventive health. It targets pre-seed and seed-stage companies that it believes are building the “new nutrition epitome” — solutions that resolve the tension between industrial efficiency and regenerative practices. The firm’s own website identifies this convergence as a single integrated value chain where healthcare is moving upstream.

Feast Ventures states that its initial investments in portfolio companies range between €150,000 and €500,000, according to the firm’s own Fund DNA disclosures. This places the fund squarely in the pre-seed and seed stage, acting as a first institutional cheque for many founders. The firm has not disclosed a total fund size or reserves for follow-on capital.

The firm’s primary investment focus is Europe, but it also explicitly states that it makes strategic investments across APAC. The balance between European and APAC deployments is not publicly detailed, and no named portfolio companies from either region have been disclosed as of the firm’s current public materials.

Feast Ventures does not publicly list any individual partners, investment committee members, or key decision-makers on its website or associated professional profiles. The team page invites contact through a general form, and no lead principal has been identified through available sources. The investment decision-making structure is not a matter of public record.

Feast Ventures is structured as an early-stage venture capital firm, not a family office. It operates from a commercial office in Munich and presents itself to the market as a fund actively seeking pitch submissions from founders. No family wealth origin or single-family backing has been disclosed in available sources.